Zoekresultaten - Jacob Aelion

  • Toon 1 - 11 resultaten van 11
Verfijn jouw resultaten
  1. 1
    T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein.

    T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein. door Mark A. Tomai, Jacob Aelion, Michael E. Dockter, G Majumdar, Dominic G. Spinella, Malak Kotb

    Gepubliceerd in 1991
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial

    Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial door Alvin F. Wells, Christopher J Edwards, Alan Kivitz, Paul Bird, Dianne Nguyen, Maria Paris, Lichen Teng, Jacob Aelion

    Gepubliceerd in 2018
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

    Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE) door Peter Nash, Kamal Ohson, Jessica A. Walsh, Nikolay Delev, Dianne Nguyen, Lichen Teng, Juan J. Gómez‐Reino, Jacob Aelion

    Gepubliceerd in 2018
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)

    Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3) door Christopher J Edwards, Francisco J. Blanco, Jeffrey Crowley, C. Birbara, Janusz Jaworski, Jacob Aelion, Randall M. Stevens, Adele R. Vessey, Xiaojiang Zhan, Paul Bird

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

    Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. door Donald Y.M. Leung, Jeffrey B. Travers, Ralph Giorno, David A. Norris, Robert Skinner, Jacob Aelion, Leila Kazemi, M H Kim, Anne E. Trumble, Malak Kotb

    Gepubliceerd in 1995
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    <scp>ABT</scp>‐122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin‐17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate

    <scp>ABT</scp>‐122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin‐17A, in Patients With Rheumatoid Arthritis With an Inadequate R... door Mark C. Genovese, Michael E. Weinblatt, Jacob Aelion, Heikki Mansikka, Paul M. Peloso, Kun Chen, Yihan Li, Mohamed I. A. Othman, Amit Khatri, Nasser Khan, Robert J. Padley

    Gepubliceerd in 2018
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    Efficacy and Safety of <scp>ABBV</scp>‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with <scp>Moderate‐to‐Severe</scp> Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, <scp>Double‐Blind</scp>, <scp>Active‐Controlled Proof‐of‐Concept</scp> Phase <scp>IIa</scp> Trial

    Efficacy and Safety of <scp>ABBV</scp>‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with <scp>Moderate‐to‐Severe</s... door Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich, Anna Zubrzycka‐Sienkiewicz, Su Chen, Yang� Yang, Dilek Arikan, Ronilda D’Cunha, Yinuo Pang, H. Küpper, Timothy R. D. J. Radstake, Howard Amital

    Gepubliceerd in 2022
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study

    One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study door Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilová, Jacob Aelion, Sang‐Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Gregory Ligozio, Shephard Mpofu

    Gepubliceerd in 2014
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis

    Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis door Mark C. Genovese, Michael E. Weinblatt, Philip J. Mease, Jacob Aelion, Paul M. Peloso, Kun Chen, Yihan Li, John Liu, Mohamed I. A. Othman, Amit Khatri, Heikki Mansikka, Piotr Leszczyński

    Gepubliceerd in 2018
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial

    Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial door Andrew J.K. Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Gabriela Alperovich, Wenjing Lü, Zailong Wang, Ahmed M. Soliman, Ann Eldred, Lisa Barcomb, Alan Kivitz

    Gepubliceerd in 2021
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial door Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, Marco Matucci‐Cerinic, Oliver Distler, Yoshihito Shima, Jacob M. van Laar, Helen Spotswood, Bridget K. Wagner, Jeffrey Siegel, Angelika Jahreis, Christopher P. Denton, Eleonora Lucero, Bernardo A. Pons‐Estel, Mariano Rivero, Guillermo Tate, Vanessa Smith, Ellen De Langhe, Rasho Rashkov, Anastas Batalov, I Goranov, Румен Стоилов, James V. Dunne, Sindhu R. Johnson, Janet Pope, Dušanka Martinović Kaliterna, Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, Cesar Ramos‐Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesiñska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, I. Castellví, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen

    Gepubliceerd in 2020
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: